Rabies
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rabies trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Rabies trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This observational study is an open-label, prospective, multi-center design. The goal is to evaluate the long-term clinical survival outcomes at 3 months and 1…
This study adopts a parallel-controlled design and includes a study group and a control group. The study group will enroll 150 special population participants (…
The Phase 1 clinical trial of the freeze-dried human rabies vaccine (human diploid cells) will be conducted on participants aged 10 to 60. This study will desig…
This is a Phase 2b, double blinded, randomized study of SYN023 compared to HyperRab® (a licensed Rabies immune globulin from human sources, HRIG) for the preven…
Rabies is caused by rabies virus with a 100% mortality rate in humans. Most of cases occur in Africa and Asia, mainly in underserved populations. Rabies is a va…